SEC Form 4 · accession 0000899243-17-006590
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curtis Hecht
Officer — See Remarks
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 2, 2017 | S | 550 | $12.00 | D | 16,160 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on September 14, 2015 and includes 550 shares acquired under the Company's 2014 Employee Stock Purchase Plan.
- F2Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on November 15, 2016.
Remarks
SENIOR VP, BUS. & CORP. DEVELOPMENT